Bassan M M, Weiler-Ravell D, Shalev O
Circulation. 1983 Sep;68(3):568-75. doi: 10.1161/01.cir.68.3.568.
Ten men with stable angina not fully relieved by optimal doses of propranolol were given on each of four mornings a single dose of 10 mg nifedipine, 120 mg verapamil, isosorbide dinitrate (5 to 30 mg, previously titrated to lower systolic blood pressure by 15 to 20 mm Hg), or placebo, in double-blind fashion. Bicycle exercise to angina was performed hourly for 8 hr thereafter. All three vasodilators increased exercise time by at least 50% by the first hour (p less than .001), with a gradually diminishing effect persisting for 6 to 8 hr (p less than .01). Although for the group there were no differences in magnitude and duration of effect among the three drugs, in five of the individual patients there were important differences in response favoring one or another vasodilator. We conclude that nifedipine, verapamil, and isosorbide dinitrate are equally effective and reasonably long-acting antianginal supplements to propranolol, although some patients may benefit more from one than another of the three.
十名患有稳定型心绞痛且服用最佳剂量普萘洛尔后症状未完全缓解的男性,在四个上午的每一天,均以双盲方式单次给予10毫克硝苯地平、120毫克维拉帕米、硝酸异山梨酯(5至30毫克,先前已滴定至收缩压降低15至20毫米汞柱)或安慰剂。此后每小时进行一次导致心绞痛的自行车运动,持续8小时。所有三种血管扩张剂在第一个小时内均使运动时间增加至少50%(p小于0.001),且逐渐减弱的效果持续6至8小时(p小于0.01)。虽然对于该组患者,三种药物在效果的程度和持续时间上没有差异,但在五名个体患者中,对一种或另一种血管扩张剂的反应存在重要差异。我们得出结论,硝苯地平、维拉帕米和硝酸异山梨酯作为普萘洛尔的抗心绞痛补充药物同样有效且作用时间合理,尽管有些患者可能从这三种药物中的一种比另一种获益更多。